2021 Transferred values declared to VVKT

Transferred values

2021 Disclosing Reports for transfered values

AbbVie, UAB

2022-06-27

Accord Healthcare AB Lietuvos filialas

2022-06-29

Accord Healthcare AB Lietuvos filialas

2022-06-29

Accord Healthcare AB Lietuvos filialas

2022-06-29

AstraZeneca Lietuva, UAB

2022-06-28

Bayer, UAB

2022-06-27

Biogen Lithuania, UAB

2022-06-28

Boehringer Ingelheim RCV GmbH & Co KG Lietuvos filialas

2022-06-28

Egis Pharmaceuticals PLC atstovybė Lietuvoje

2022-06-30

Eli Lilly Lietuva, UAB

2022-06-29

Grindeks, AB filialas

2022-06-28

IPSEN Pharma SAS Lietuvos filialas

2022-06-27

Johnson & Johnson, UAB

2022-06-30

Medochemie, UAB

2022-06-30

Merck Serono, UAB

2022-06-27

Merck Sharp & Dohme, UAB

2022-06-27

Morfėjus, UAB

2022-06-30

Mylan Healthcare, UAB

2022-06-26

Novo Nordisk Pharma, UAB

2022-06-26

Pfizer Luxembourg SARL filialas

2022-06-27

Polpharma, farmacinės įmonės S. A. atstovybė

2022-06-29

Roche Lietuva, UAB

2022-06-28

Servier Pharma, UAB

2022-06-27

SIA Novartis Baltics Lietuvos filialas

2022-06-29

Swixx Biopharma, UAB

2022-06-28

Takeda, UAB

2022-06-27

Companies that had no transferred values during year 2021

Berlin Chemie Menarini Baltic, UAB

Gedeon Richter Plc. atstovybė Lietuvoje

Zentiva Group, a.s. Lietuvos filialas

Disclosure reports of 2023 transfers of value

Disclosure reports of 2022 transfers of value

Disclosure reports of 2020 transfers of value

Disclosure reports of 2019 transfers of value

Disclosure reports of 2018 transfers of value

Disclosure reports of 2017 transfers of value

Disclosure reports of 2016 transfers of value

Disclosure reports of 2015 transfers of value